Author:
Pritzlaff Mary,Summerour Pia,McFarland Rachel,Li Shuwei,Reineke Patrick,Dolinsky Jill S.,Goldgar David E.,Shimelis Hermela,Couch Fergus J.,Chao Elizabeth C.,LaDuca Holly
Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. The NCCN Clinical Practice Guidelines in Oncology™ Genetic/Familial High-Risk Assessment: Breast and Ovarian V2.2016. National Comprehensive Cancer Network, Inc. 2016.
http://www.nccn.org/
. Accessed 22 Sept 2016
2. Thorlacius S, Sigurdsson S, Bjarnadottir H et al (1997) Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60(5):1079–1084
3. Couch FJ, Faird LM, SeSHano ML et al (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 13(1):123–125
4. Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480–1490
5. Kwong A, Ng EK, Wong CL et al (2012) Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis. PLoS ONE 7(9):e43994
Cited by
112 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献